Danlin Yang

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

BIOGRAPHY

Danlin Yang has not added Biography.

If you are Danlin Yang and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

Efficient Qualitative and Quantitative Determination of Antigen-induced Immune Responses.

The Journal of biological chemistry Jul, 2016 | Pubmed ID: 27288409

Comparison of biosensor platforms in the evaluation of high affinity antibody-antigen binding kinetics.

Analytical biochemistry Sep, 2016 | Pubmed ID: 27365220

Dataset of the binding kinetic rate constants of anti-PCSK9 antibodies obtained using the Biacore T100, ProteOn XPR36, Octet RED384, and IBIS MX96 biosensor platforms.

Data in brief Sep, 2016 | Pubmed ID: 27547794

INSTITUTIONS

Boehringer Ingelheim Pharmaceuticals, Inc.

JOVE ARTICLES

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Danlin Yang¹,

Ajit Singh²,

Helen Wu¹,

Rachel Kroe-Barrett¹

¹Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals, Inc.,

²The Fu Foundation School of Engineering and Applied Science, Columbia University

Biochemistry

Privacy

Policies

Recommend to library

JoVE NEWSLETTERS

Research

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive

Education

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Faculty Site

Authors

Overview
Publishing Process
Editorial Board
Scope and Policies
Peer Review
FAQ
Submit

Librarians

Overview
Testimonials
Subscriptions
Access
Resources
Library Advisory Board
FAQ

ABOUT JoVE

Overview
Leadership
Blog
JoVE Help Center

Danlin Yang

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Biotherapeutics Discovery,Immune Modulation and Biotherapeutics Discovery,Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery

Boehringer Ingelheim Pharmaceuticals, Inc.

Determination of High-affinity Antibody-antigen Binding Kinetics Using Four Biosensor Platforms

Department of Biotherapeutics Discovery,
Immune Modulation and Biotherapeutics Discovery,
Department of Biotherapeutics Discovery, Immune Modulation and Biotherapeutics Discovery